We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Research Priorities Target Methods for Assessing Generics, Advanced Therapies
FDA’s Research Priorities Target Methods for Assessing Generics, Advanced Therapies
The FDA has laid out a regulatory research agenda for the year that includes identifying better methods for assessing generics, improving drug safety, biosimilars development and finding ways to assess advanced, new drugs as areas where the agency would like to sponsor research.